Nine-Year Median Follow-up of Cardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference44 articles.
1. Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013;Noone;Cancer Epidemiol Biomarkers Prev,2017
2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989
3. Cancer therapy–induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies;Hahn;J Am Heart Assoc,2014
4. Early breast cancer therapy and cardiovascular injury;Jones;J Am Coll Cardiol,2007
5. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines;Curigliano;Ann Oncol,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer;Clinical Breast Cancer;2024-07
2. Neoadjuvant Trastuzumab-Based Chemotherapy and Pathologic Complete Response in HER2-Positive Breast Cancer; A Systematic Review;2023-07-31
3. Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors;Frontiers in Cardiovascular Medicine;2023-01-25
4. Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer;Cancer Treatment and Research Communications;2023
5. Antineoplastics;Reactions Weekly;2022-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3